Skip to main content
SpringerLink
Log in

First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT)

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Hereditary haemorrhagic teleangiectasia (HHT) is most notably characterized by vulnerable vascular formations of the nasal superficial mucosa. Epistaxis is one of the most common symptoms of the afflicted patients, with an incidence of more than 90 %. A variable series of treatments have been described, ranging from nasal ointments to the complete surgical occlusion of the nose. The objective of this pilot study is the presentation of first experiences in treating patients suffering from HHT and chronically recurrent epistaxis with an individual nasal olive made from silicone. Eleven patients (six men, five women) aging from 44 to 80 years with known HHT were treated at the ENT department of Homburg/Saar between October 2008 and July 2012 because of nasal bleeding by Nd:YAG laser or argon plasma coagulation. After the surgical treatment, an imprint of the nasal aditus was taken to manufacture an individual custom-made silicone nasal olive. Patients were wearing the nasal olive for 3–8 h a day. Check-ups were made every 6 months. Epistaxis severity score (ESS) was used pre- and post-nasal olive application. The observation period was 12–48 months. The utilization of the silicone nasal olive led to a distinct reduction of epistaxis events. Apart from the nasal olive, our patients needed no further treatment of the nose during the observation period except for a nasal ointment. Insertion and removal of the nasal olive were handled by the patients themselves. The local manipulation in handling the nasal olive caused no epistaxis itself. A significant improvement of the ESS and satisfaction was reported in all patients. Use of an individually manufactured silicone nasal olive is a promising extension to the established treatments of epistaxis in HHT patients. Tolerance towards this treatment by the patients was high due to the low personal burden and encumbrance. The extended use of the presented method in HHT patients may be beneficial. However, a more prolonged observation period is necessary in the future to judge the long-term efficiency of individual nasal olives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rendu M (1896) Épistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Bull Mém Soc Méd Hôp Paris 13:731–733

    Google Scholar 

  2. Osler W (1901) On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Johns Hopkins Hops Bull 12:333–337

    Google Scholar 

  3. Weber FP (1907) Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages. Lancet 2:160–162

    Google Scholar 

  4. Hanes FM (1907) Multiple hereditary telangiectases cause hemorrhage (hereditary hemorrhagic telangiectasia). Johns Hopkins Hosp Bull 20:63–73

    Google Scholar 

  5. Parkin JL, Dixon JA (1985) Argon laser treatment of head and neck vascular lesions. Otolaryngol Head Neck Surg 93:211–216

    CAS  PubMed  Google Scholar 

  6. Shapsay SM (1984) Oliver P treatment of hereditary hemorrhagic telangiectasia by Nd-YAG laser photocoagulation. Laryngoscope 94:1554–1556

    Google Scholar 

  7. Werner JA, Lippert BM, Geisthoff UW, Rudert H (1997) Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia. Laryngorhinootologie 76:495–501 (Article in German)

    Article  CAS  PubMed  Google Scholar 

  8. Shah RK, Dhingra JK, Shapshay SM (2002) Hereditary hemorrhagic telangiectasia: a review of 76 cases. Laryngoscope 112:767–773

    Article  PubMed  Google Scholar 

  9. Byahatti SV, Rebeiz EE, Shapshay SM (1997) Hereditary hemorrhagic telangiectasia: what the otolaryngologist should know. Am J Rhinol 11:55–62

    Article  CAS  PubMed  Google Scholar 

  10. Vickery CL, Kuhn FA (1996) Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia. South Med J 89:78–80

    Article  CAS  PubMed  Google Scholar 

  11. Karapantzos I, Tsimpiris N, Goulis DG, Van Hoecke H, Van Cauwenberge P, Danielides V (2005) Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:yAG laser and quality of life assessment using the HR-QoL questionnaire. Eur Arch Otorhinolaryngol 262:830–833 (Epub 2005 Mar 1)

    Article  PubMed  Google Scholar 

  12. Kardos TB, Holt T, Ferguson MM (1989) Histological evaluation of the effect of a miniature carbon dioxide laser on oral mucosa. Int J Oral Maxillofac Surg 18:117–120

    Article  CAS  PubMed  Google Scholar 

  13. Bergler W, Götte K, Riedel F, Back W, Hörmann K (1998) Argon plasma coagulation in treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa. HNO 46:228–232 (Article in German)

    Article  CAS  PubMed  Google Scholar 

  14. Saunders WH (1960) Septal dermoplasty for control of nosebleeds caused by hereditary hemorrhagic telangiectasia or septal perforations. Trans Am Acad Ophthalmol Otolaryngol 64:500–506

    CAS  PubMed  Google Scholar 

  15. McCaffrey TV, Kern EB, Lake CF (1977) Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases. Arch Otolaryngol 103:627–630

    Article  CAS  PubMed  Google Scholar 

  16. Fiorella ML, Ross D, Henderson KJ, White RI Jr (2005) Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Laryngoscope 115:301–305

    Article  PubMed  Google Scholar 

  17. Levine CG, Ross DA, Henderson KJ, Leder SB, White RI Jr (2008) Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 138:721–724

    Article  PubMed  Google Scholar 

  18. Young A (1967) Closure of the nostrils in atrophic rhinitis. J Laryngol Otol 81:515–524

    Article  CAS  PubMed  Google Scholar 

  19. Brooker DS, Cinnamond MJ (1991) Young’s procedure in the treatment of epistaxis. J Laryngol Otol 105:847–848

    Article  CAS  PubMed  Google Scholar 

  20. Gluckman JL, Portugal LG (1994) Modified Young’s procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope 104:1174–1177

    Article  CAS  PubMed  Google Scholar 

  21. Lund V, Howard DJ (1997) Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia. J Laryngology and Otology J Laryngol Otol 111:30–33

    CAS  Google Scholar 

  22. Pau H, Carney AS, Murty GE (2001) Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): otorhinolaryngological manifestations. Clin Otolaryngol Allied Sci 26:93–98

    Article  CAS  PubMed  Google Scholar 

  23. Strother CM, Newton TH (1976) Percutaneous embolization to control epistaxis in Rendu-Osler-Weber disease. Arch Otolaryngol 102:58–60

    Article  CAS  PubMed  Google Scholar 

  24. Weissman JL, Jungreis CA, Johnson JT (1995) Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia. Am J Otolaryngol 16:138–140

    Article  CAS  PubMed  Google Scholar 

  25. Harrison DFN (1982) Use of estrogen in treatment of familiar hemorrhagic teleangiectasia. Laryngoscope 92:314–319

    Article  CAS  PubMed  Google Scholar 

  26. Sadick H, Riedel F, Oulmi J, Hörmann K, Bergler WF (2003) Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa. HNO 51:118–124 (Article in German)

    Article  CAS  PubMed  Google Scholar 

  27. Vase P (1981) Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial. Acta Med Scand 209:393–396

    Article  CAS  PubMed  Google Scholar 

  28. Pizzi G, Turcato G, Polico R, Busetto M, Antonello M, Princivalli M (1995) Brachytherapy of epistaxis in Rendu-Osler disease. Indications, technic, results. Radiol Med 89:861–864 Article in Italian

    CAS  PubMed  Google Scholar 

  29. Folz BJ, Zoll B, Alfke H, Toussaint A, Maier RF, Werner JA (2006) Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents. Eur Arch Otorhinolaryngol 263(1):53–61 Epub 2005 Jun 24

    Article  PubMed  Google Scholar 

  30. Folz BJ, Wollstein AC, Alfke H, Dünne AA, Lippert BM, Görg K, Wagner HJ, Bien S, Werner JA (2004) The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study. Eur Arch Otorhinolaryngol 261(9):509–516 (Epub 2003 Dec 17)

    Article  PubMed  Google Scholar 

  31. Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, Roux A, Carette MF, Gilbert-Dussardier B, Hatron PY, Lacombe P, Lorcerie B, Rivière S, Corre R, Giraud S, Bailly S, Paintaud G, Ternant D, Valette PJ, Plauchu H, Faure F (2012) Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA 307:948–955

    Article  CAS  PubMed  Google Scholar 

  32. Guldmann R, Dupret A, Nivoix Y, Schultz P, Debry C (2012) Bevacizumab nasal spray: noninvasive treatment of epistaxis in patients with Rendu-Osler disease. Laryngoscope 122:953–955

    Article  CAS  PubMed  Google Scholar 

  33. Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA (2010) An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 120:838–843

    Article  PubMed  Google Scholar 

  34. Folz BJ, Lippert BM, Wollstein AC, Tennie J, Happle R, Werner JA (2004) Mucocutaneous telangiectases of the head and neck in individuals with hereditary hemorrhagic telangiectasia—analysis of distribution and symptoms. Eur J Dermatol. 14:407–411

    PubMed  Google Scholar 

  35. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66–67

    Article  CAS  PubMed  Google Scholar 

  36. Al Kadah B, Bumm K, Wolf G, Schneider M, Schick B (2011) A new innovative approach in treatment of hereditary haemorrhagic teleangiectasia (HHT): a nasal olive. GMS Curr Posters Otorhinolaryngol Head Neck Surg 7:Doc61

    Google Scholar 

  37. Folz BJ, Chirtesiu AM, Konnerth CG (2013) Customized nasal breathing tubes as an alternative to Young’s procedure in HHT patients with epistaxis Preliminary results. Hematology Reports Volume 3(suppl 1):137

    Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge the worthful contribution of Dietmar Hecker in performing the statistical analysis.

Conflict of interest

There is no financial support. There is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, University Medical Center, Kirrberger Straße, 66421, Homburg/Saar, Germany

    Basel Al Kadah, George Papaspyrou & Bernhard Schick

  2. Institute of Anaplastology Schneider, Zweibrücken, Germany

    Mathias Schneider

Authors
  1. Basel Al Kadah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Papaspyrou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mathias Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bernhard Schick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Basel Al Kadah.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al Kadah, B., Papaspyrou, G., Schneider, M. et al. First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT). Eur Arch Otorhinolaryngol 272, 117–122 (2015). https://doi.org/10.1007/s00405-014-3086-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-014-3086-3

Keywords

Search

Navigation